Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial Source: Eur Respir J, 51 (4) 1701389; 10.1183/13993003.01389-2017 Year: 2018
Effectiveness of azithromycin (AZ) in patients with community-acquired pneumonia (CAP): an evidenced-based meta-analysis of randomized controlled trials (RCTs) Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001
Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Outcomes reported in pneumonia randomized controlled trials Source: Virtual Congress 2021 – Pneumonia Year: 2021
Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies Source: ERJ Open Res, 8 (1) 00489-2021; 10.1183/23120541.00489-2021 Year: 2022
Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Randomized, controlled trial of efficacy and safety of cefepime in late-onset ventilator-associated pneumonia in infants Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006
Targeting treatable traits in severe asthma: a randomised controlled trial Source: Eur Respir J, 55 (3) 1901509; 10.1183/13993003.01509-2019 Year: 2020
Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009
Factors affecting patients’ decision to adjust treatment; secondary analysis of a randomised trial of treatment optimisation in patients with severe asthma Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021
Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021
Cluster randomised controlled trial of the effect of introduction of an acute wheeze/asthma integrated care pathway on patient outcome Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006
Investigation of protein C activity as a prognostic factor for HCAP; single-center observational study Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID Year: 2021
Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in IIPs: Secondary analysis of SETUP trial Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017